The cost effectiveness of infliximab for severe treatment-resistant rheumatoid arthritis in the UK. (Q53854537)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | The cost effectiveness of infliximab for severe treatment-resistant rheumatoid arthritis in the UK. |
scientific article |
Statements
The cost effectiveness of infliximab for severe treatment-resistant rheumatoid arthritis in the UK. (English)
Marco Barbieri
John B Wong
Michael Drummond
1 January 2005
23
6
607-618
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference